SteriLux is an innovative startup offering a low-temperature ozone gas sterilization device. Founded in 2014 and headquartered in Switzerland, the company prides itself on developing a sterilization system that complies with the most demanding medical regulations. With a focus on Swiss quality and innovation, SteriLux aims to revolutionize the approach to infection control within the healthcare industry. The company recently secured a Fr.1.78M Venture Round investment on December 18, 2019, with One Creation as the investing party. This recent influx of investment demonstrates a promising future for SteriLux as it continues to make strides in the healthcare technology sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Fr.1.78M | 1 | 18 Dec 2019 | |
Debt Financing | Fr.500.00K | 1 | Foundation for Technological Innovation (FIT) | 06 Mar 2019 |
Debt Financing | Fr.100.00K | 1 | Foundation for Technological Innovation (FIT) | 22 Jun 2016 |
Non Equity Assistance | Unknown | 1 | 19 May 2016 | |
Seed Round | Fr.500.00K | - | 11 Mar 2016 |
No recent news or press coverage available for SteriLux.